Khi được bạn cho phép, chúng tôi sử dụng phân tích giới hạn, chú trọng quyền riêng tư để hiểu hành trình nghiên cứu nào hiệu quả. Chúng tôi không dùng trình theo dõi quảng cáo hoặc ghi lại phiên. Bạn có thể thay đổi lựa chọn này trong Tùy chọn. Đọc Chính sách quyền riêng tư.
Quote this valuation with its source: Fair value, Potential value and the price at analysis.
FAQ
CTSH — frequently asked questions
Is Cognizant Technology Solutions Corporation overvalued?
In our latest published analysis dated 2026-10-05, CTSH looks meaningfully undervalued. The price recorded at analysis is 58,2 USD versus our fair value of 94,4 USD; the high endpoint is presented separately as potential value of 117 USD. That implies roughly 62.2% upside to fair value at that date.
Our latest published report, analyzed 2026-10-05, gives CTSH a fair value of 94,4 USD and a potential value of 117 USD. The conclusion is triangulated across multiple valuation models and weighted by reliability for Cognizant Technology Solutions Corporation's archetype; it is a dated research output, not a live price.
Should I buy CTSH now?
Our latest published rating for CTSH, analyzed 2026-10-05, is Strong Buy. Cognizant Technology Solutions Corporation looks meaningfully undervalued at the analysis-date price of 58,2 USD versus fair value of 94,4 USD; potential value is 117 USD. This is research for educational purposes, not personalized investment advice.
What are the biggest risks for CTSH?
The dedicated bear-case section in our report analyzed 2026-10-05 documents Cognizant Technology Solutions Corporation's material risks, evidence, thresholds, and thesis-invalidation conditions. Scenario-specific explanations remain in that section so the report does not repeat or decontextualize them elsewhere.
What is CTSH's rating?
Our latest published rating for CTSH, analyzed 2026-10-05, is Strong Buy, with a published moat assessment of 6.5/10 (Narrow). It reflects our fair value of 94,4 USD, the potential value of 117 USD, and the price recorded at analysis (58,2 USD).
Báo cáo này chưa được dịch. Hãy làm mới sau vài phút khi hàng đợi dịch xử lý xong.
§1 Tóm tắt điều hànhEN
Câu trả lời trong 30 giâyStrong Buy
Giá so với giá trị
Giá
$58.17
Giá trị hợp lý
$94.37
Giá trị tiềm năng
$116.80
Tính đến
2026-10-05
Vì sao luận điểm có thể đúng
Accelerating enterprise adoption of generative AI, cloud migration, and core platform modernization across Fortune 500 accounts expands contract renewal values and new bookings.
Điều gì sẽ thay đổi quan điểm của chúng tôi
Consolidated organic revenue growth decelerating below 0.0% YoY, or constant-currency revenue growth slowing below 2.0% for two consecutive quarters.
We rate Cognizant Technology Solutions Corporation as a Strong Buy with an intrinsic Fair value of $94.37 per share, offering 62.23% upside from the analysis price of $58.17.
We assign a Strong Buy rating to Cognizant Technology Solutions Corporation. For an investor, this recommendation reflects substantial undervaluation of Cognizant's durable commercial relationships, highly recurring revenue, and consistent capital return through share repurchases, offering an attractive long-term opportunity for capital growth.
The report was prepared at a price of $58.17 on October 5, 2026. Our intrinsic valuation concludes with a Fair value of $94.37 per share and a Potential value of $116.80 per share. At the report-date price, the stock trades at a 38.36% discount to Fair value, which represents an implied upside of 62.23%. If digital enterprise modernization and operational efficiency reach our Potential value, the upside to that upper level would be 100.79%.
The principal risk to this investment is a prolonged slowdown in North American corporate technology budgets driven by elevated interest rates. Because North America accounts for $15,780M, or 74.8% of Cognizant's $21,108M total revenue,, widespread spending delays would push organic revenue growth below 0.0% year over year and miss consensus FY2027 revenue targets of $23,250M. If corporate clients defer major contracts while offshore delivery labor costs rise, operating margin would fall below 13.50% from the 16.05% reported in FY2025, reducing cash flow and share repurchases.1,2,6,7
The main reason this investment can succeed is Cognizant's strong competitive positioning and high cash conversion in regulated industry sectors. Health Sciences delivered $6,347M in revenue with a 16.21% operating margin,, and Financial Services generated $6,173M with a 19.97% operating margin in FY2025,. Because the business requires minimal physical capital reinvestment ($288M in FY2025 capital expenditures), the company generated $2,595M in free cash flow. Cognizant directs this surplus cash into share buybacks, lowering diluted shares from 489M in FY2025 to 473M by October 2026. This ongoing reduction in shares outstanding concentrates future earnings, supporting projected diluted EPS of $6.33 in FY2027 and driving the share price toward our Fair value of $94.37.1,3,5,6,7
Deep Vertical Entrenchment and Procedural Switching Costs
Cognizant's primary industry segments in Health Sciences ($6,347M revenue) and Financial Services ($6,173M revenue) are embedded into client regulatory workflows and core banking platforms, securing operating margins of 16.21% and 19.97%,.7
Because IT services require modest physical infrastructure, Cognizant spent just $288M on capital expenditures in FY2025 against $2,883M in operating cash flow. This generated $2,595M in free cash flow, converting 116.37% of GAAP net income and funding persistent share repurchases.3,5,6
Attractive Valuation Disconnect Against Normalized Earnings Power
At $58.17, Cognizant trades at 9.41x forward earnings, a 38.36% discount to our Fair value of $94.37. This valuation gap offers 62.23% upside as per-share earnings expand toward consensus FY2027 diluted EPS of $6.33.1,3
Khuyến nghị của hãng
Cognizant Technology Solutions Corporation is rated Strong Buy because its enterprise modernization scale, high-margin healthcare and banking platforms, and $2,595M in annual free cash flow drive reliable per-share intrinsic compounding against an unwarranted 38.36% valuation discount.5
Tổng quan công ty
Cognizant Technology Solutions Corporation is a leading global provider of information technology consulting, application modernization, and digital business operations. The company helps enterprise clients modernize legacy IT infrastructure, optimize business processes, and deploy digital and artificial intelligence systems. Cognizant delivers its solutions through major industry-aligned operating segments, including Financial Services, Health Sciences, Products and Resources, and Communications, Media and Technology. Across these verticals, the company integrates deep industry domain knowledge with specialized technical capabilities in cloud architecture, data engineering, enterprise applications, and digital workflows,.
In its primary Financial Services and Health Sciences markets, Cognizant serves major global banks, capital markets participants, insurance carriers, healthcare payers, healthcare providers, and life sciences corporations. Clients engage Cognizant to update core banking and policy administration platforms, strengthen operational resilience, implement predictive analytics, and comply with strict data protection and regulatory standards,. In FY2025, Health Sciences generated $6,347M in revenue, while Financial Services contributed $6,173M.
Through its Products and Resources segment, Cognizant partners with global manufacturers, automakers, retailers, consumer goods enterprises, logistics providers, and energy and utility companies. Solutions focus on smart factory automation, supply chain optimization, IoT fleet tracking, and electrical grid modernization. The company's dedicated security practice protects enterprise environments through governance, risk and compliance advisory, zero-trust identity and access management, and cloud security engineering. Geographically, Cognizant generates the majority of its business in North America ($15,780M in FY2025 revenue) and Europe ($4,012M), supported by cost-effective offshore and nearshore delivery centers.
§2 Kịch bản tiêu cựcEN
Under a combined stress scenario where North American corporate IT spending freezes due to high interest rates (5.24% risk-free rate) and offshore delivery wage inflation outpaces billing rate adjustments, Cognizant's revenue growth would stagnate below 0.0% YoY, failing to meet consensus FY2027 revenue expectations of $23,250M. Concurrently, consolidated operating margin would compress from 16.05% in FY2025 ($3,389M operating income on $21,108M revenue,) toward historical trough levels below 13.50%. Annual free cash flow generation would deteriorate from $2,595M, curtailing share repurchase execution from the 473M share baseline and testing balance sheet liquidity ($1,901M cash against $2,094M total debt).
In the bear case, prolonged macroeconomic headwinds and tight corporate budgets prompt enterprise clients to delay discretionary consulting projects and seek vendor rate concessions. Offshore technical wage inflation outpaces billing rate renegotiations, compressing operating margins toward historical trough levels. While long-term managed services contracts provide baseline operational continuity, cash flow generation slows and share repurchase capacity is diminished. Downside risk is examined qualitatively through the dedicated kill scenarios and early deterioration thresholds.
Các cách luận điểm này có thể đổ vỡ
Offshore Delivery Wage Inflation and Utilization Drop Compressing Operating Margin
If offshore delivery wage inflation in India accelerates without contract rate renegotiation, operating margin would fall below 13.5% (down from 16.05% in FY2025 based on $3,389M operating income on $21,108M revenue,), mirroring historical trough levels of 12.70% in 2020 and 13.89% in 2023.6
FV impact
-2.9%
Operating margin 3 points lower throughout
Tín hiệu cảnh báo sớm cần theo dõi
Năm diễn biến có thể làm suy yếu luận điểm đầu tư của chúng tôi.
Offshore delivery wage inflation in India accelerates without contract rate renegotiation, or billable utilization deteriorates, compressing profitability toward historical trough levels of 12.70% in 2020 and 13.89% in 2023.
Cognizant maintains a Narrow economic moat supported by moderate switching costs embedded in large enterprise accounts and a formidable global delivery scale cost advantage. The company's relationships with Fortune 500 corporate clients are cemented through multi-year managed services contracts, complex systems integration, and proprietary industry-specific platforms. While specialized peers such as Gartner (IT) command higher gross margins of 69.63% via syndicated research, Cognizant's delivery scale ($21,108M revenue) enables comprehensive digital transformation execution across massive client application portfolios.
The moat is most pronounced in regulated industry verticals where procedural switching costs are high. Health Sciences ($6,347M revenue, $1,029M operating income,) and Financial Services ($6,173M revenue, $1,233M operating income,) together generated 59.3% of consolidated FY2025 revenue and 64.9% of segment operating profit. Replacing Cognizant in these environments entails operational disruptions, data security risks, and regulatory compliance friction that corporate boards actively avoid.
However, the moat remains Narrow rather than Wide due to the ongoing risk of commoditization in standard application maintenance and intense competition from global systems integrators. Delivery center wage inflation in India and rapid client adoption of automated code tools exert downward pressure on routine billable hours. Consequently, a 5-year explicit forecast horizon followed by a 5-year competitive fade appropriately balances Cognizant's structural switching costs against long-term technological and pricing pressures.
01High switching costs in mission-critical enterprise workflows — Deep operational integration, proprietary domain IP, and regulatory compliance workflows across Health Sciences ($6,347M revenue) and Financial Services ($6,173M revenue) make vendor replacement costly, operationally risky, and disruptive for Fortune 500 enterprise clients.Moderate
02Global delivery network scale and cost advantage — Cognizant's massive scale with $21,108M in FY2025 revenue and established offshore delivery footprint in India provide cost-efficient execution and project staffing flexibility that smaller specialized peers cannot replicate at enterprise scale, supporting consolidated operating margins of 16.05%.
Mối đe dọa đã biết với lợi thế cạnh tranh
Mối đe dọa
Mức độ
Mốc thời gian
Giảm thiểu
Offshore delivery wage inflation and technical talent retention costs
medium
12 to 24 months
Pyramid rationalization, expanding delivery centers into tier-2/3 cities in India, automation of routine application maintenance, and fixed-price contract repricing.
Discretionary enterprise IT spending contraction under elevated interest rates
The highlighted cell is Fair value when every assumption sits at its base level ($94.37). Each row and column shows what Fair value becomes when one assumption moves.
Free cash flow to the firm stays positive in the first projected year at $2.4B after modeled reinvestment of $324.7M, with terminal value at 77.7% of enterprise value. A sudden drop in free cash flow is not projected unless capital spending relative to revenue, reinvestment, or gross margin resets materially.
The base case represents the modal expected trajectory, reflecting steady execution across multi-year enterprise contracts, mid-single-digit top-line growth, and modest margin expansion driven by delivery automation. Regulated domain stability in Health Sciences and Financial Services sustains double-digit operating margins and robust cash generation, while ongoing share repurchases support diluted earnings compounding. This path establishes Fair value at $94.37 with an assigned probability of 60.0%, representing 62.2% upside from $58.17.
Enterprise digital modernization demand accelerates with double-digit growth in specialized vertical solutions
Operating margins expand through delivery automation and favorable billing rates
§7 Cây quyết định lợi nhuậnEN
Vượt
Maintain Strong Buy; Reaffirm high conviction allocation, monitor share repurchase execution, and re-examine full-year margin expansion milestones.
Kích hoạt: Quarterly revenue and operating margin exceed consensus expectations alongside expanding full-year guidance and accelerated large deal bookings.
A material operational beat driven by accelerating digital modernization and healthcare deal conversion confirms thesis momentum and expands cash generation.
Đúng kỳ vọng
Maintain Strong Buy; Maintain planned portfolio sizing, verifying that free cash flow conversion remains robust and working capital remains disciplined.
Kích hoạt: Quarterly revenue and diluted earnings align with consensus expectations with stable constant-currency guidance.
In-line operational results confirm steady execution across core enterprise accounts and validate the multi-year compounder thesis.
Hụt
Downgrade the rating; Review position allocation, re-examine offshore wage inflation metrics, and verify whether deceleration reflects isolated client budget timing or systemic market share loss.
Kích hoạt: Quarterly revenue contracts sequentially with operating margins falling below guided levels due to offshore wage pressure and project delays.
A significant operational miss driven by discretionary project freezes or unhedged wage inflation impairs near-term earnings power and requires reassessment of the margin normalization trajectory.
Chất lượng lợi nhuận
Earnings quality is supported by robust cash flow generation where cash conversion consistently exceeds GAAP net income. Working capital management remains disciplined with low unbilled receivables, and the asset-light delivery structure requires minimal routine maintenance capital expenditures. High recurring revenue from multi-year managed services contracts in regulated healthcare and banking verticals provides cash flow visibility and insulates reported operating income from aggressive accounting adjustments.
Xu hướng dự báo
Consensus earnings and revenue revisions have stabilized following the recent quarterly financial release. Sell-side analyst revisions remain balanced as steady execution across healthcare and financial services offsets macroeconomic caution across North American enterprise IT budgets.
Chỉ số cần theo dõi trước khi công bố
01
Chỉ số:
Consolidated operating margin trajectory and delivery automation
Hiện tạiOperating margins remain healthy above historical trough levels supported by delivery optimization programs.
Vì sao quan trọng
Operating margin durability indicates whether delivery center automation and billing rate adjustments offset offshore wage inflation, sustaining enterprise earnings power and cash generation.
Cognizant demonstrates exceptional cash conversion characteristics. In FY2025, operating cash flow reached $2,883M and capital expenditures were just $288M, yielding free cash flow of $2,595M. This converted 116.37% of GAAP net income of $2,230M. For the first six months of FY2026 ended June 30, 2026, operating cash flow was $832M and capex was $175M, generating year-to-date free cash flow of $657M. The asset-light nature of IT services delivery ensures that over 85% of operating income translates into deployable shareholder cash.5,6
Cognizant maintains an attractive economic spread, with ROIC of 13.74% comfortably exceeding its computed cost of capital (moderate Ke of 8.96% and WACC of 8.64%). Capital-light operations ($288M capex) and high asset turnover sustain value creation across business cycles.
ROIC of 13.74% exceeds WACC of 8.64% by 5.10 percentage points, creating consistent economic value for equity holders.
Operating cash flow of $2,883M and of $288M produced $2,595M in , converting 116% of ($2,230M).
Doanh thu mới nhất21,1 T US$CAGR doanh thu +5,1%
Biên hoạt động16,1%10 kỳ tài chính
Dòng tiền tự do mới nhất2,6 T US$FY2025
Tiền mặt ròng339 Tr US$FY2025
Phân tích báo cáo kết quả kinh doanhQuy mô kinh doanh chuyển thành lợi nhuận báo cáo như thế nào.
StockMarketAgent.AI
Doanh thu21,1 T US$Giá vốn doanh thu−14 T US$Lợi nhuận gộp7,1 T US$Chi phí hoạt động−3,7 T US$Lợi nhuận hoạt động3,4 T US$Các khoản ngoài hoạt động và thuế−1,2 T US$Lợi nhuận ròng2,2 T US$
Dữ liệu lịch sử tài chính
Doanh thu
21.108.000.000 US$
Giá vốn doanh thu
13.991.000.000 US$
Lợi nhuận gộp
7.117.000.000 US$
Chi phí hoạt động
3.728.000.000 US$
Lợi nhuận hoạt động
3.389.000.000 US$
Các khoản ngoài hoạt động và thuế
-1.159.000.000 US$
Lợi nhuận ròng
2.230.000.000 US$
Tổng quan bảng cân đối kế toánCách tài sản đã báo cáo được nắm giữ và tài trợ trong kỳ đã chọn.
StockMarketAgent.AI
Cơ cấu tài sảnNguồn tài trợ
Tổng tài sản20,7 T US$Tiền mặt1,9 T US$Tài sản ngắn hạn7,8 T US$Tổng nợ phải trả5,7 T US$Nợ ngắn hạn3,7 T US$Vốn chủ sở hữu15 T US$
Dữ liệu phân tích bảng cân đối kế toán
Tổng tài sản
20.692.000.000 US$
Tiền mặt
1.901.000.000 US$
Tài sản ngắn hạn
7.818.000.000 US$
Tổng nợ phải trả
5.677.000.000 US$
Nợ ngắn hạn
3.659.000.000 US$
Vốn chủ sở hữu
15.015.000.000 US$
Cầu nối dòng tiềnDòng tiền từ hoạt động chuyển thành dòng tiền tự do như thế nào trong FY2025.
StockMarketAgent.AI
Đối chiếu dòng tiền hoạt động
Lợi nhuận ròng2,2 T US$Khấu hao và phân bổ+550 Tr US$Thù lao bằng cổ phiếu+181 Tr US$Điều chỉnh hoạt động khác−78 Tr US$Dòng tiền hoạt động2,9 T US$
Đối chiếu tiền đầu kỳ đến cuối kỳ
Tiền đầu kỳ2,2 T US$Dòng tiền hoạt động+2,9 T US$Dòng tiền đầu tư−230 Tr US$Dòng tiền tài chính−2,3 T US$Ảnh hưởng tỷ giá+22 Tr US$Tiền cuối kỳ2,6 T US$
2,9 T US$ − 288 Tr US$Dòng tiền tự do 2,6 T US$
Dữ liệu cầu nối dòng tiền
Lợi nhuận ròng
2.230.000.000 US$
Dòng tiền vào từ hoạt động
2.961.000.000 US$
Khấu hao và phân bổ
550.000.000 US$
Thù lao bằng cổ phiếu
181.000.000 US$
Dòng tiền hoạt động
2.883.000.000 US$
Dòng tiền ra từ hoạt động
78.000.000 US$
Tiền sẵn có
5.136.000.000 US$
Tiền đầu kỳ
2.231.000.000 US$
Ảnh hưởng tỷ giá
22.000.000 US$
Dòng tiền ra từ đầu tư
230.000.000 US$
Dòng tiền ra từ tài chính
2.272.000.000 US$
Tiền cuối kỳ
2.634.000.000 US$
Dòng tiền đầu tư
-230.000.000 US$
Dòng tiền tài chính
-2.272.000.000 US$
Doanh thu theo phân khúc hoạt độngTỷ trọng trong tổng doanh thu của 2025-12-31.
21,1 T US$Tổng doanh thu
Doanh thu theo phân khúc hoạt độngTỷ trọng
Health Sciences6,3 T US$30,1%+7% so với cùng kỳ
Financial Services6,2 T US$29,2%+7,3% so với cùng kỳ
Productsand Resources5,3 T US$25%+10,5% so với cùng kỳ
Communications Mediaand Technology3,3 T US$15,6%+1% so với cùng kỳ
Nguồn: SEC EDGAR · Nộp ngày 2026-02-12 · SEC EDGAR
Dữ liệu cơ cấu doanh thu: Doanh thu theo phân khúc hoạt động
Doanh thu theo phân khúc hoạt động
Doanh thu
Tỷ trọng
so với cùng kỳ
Health Sciences
6,3 T US$
30,1%
7%
Financial Services
6,2 T US$
29,2%
7,3%
Productsand Resources
5,3 T US$
25%
10,5%
Communications Mediaand Technology
3,3 T US$
15,6%
1%
Doanh thu và lợi nhuậnQuy mô kinh doanh chuyển thành lợi nhuận báo cáo như thế nào.
Tiền mặt và nợThanh khoản sẵn có so với tổng dư nợ.
Tạo dòng tiềnDòng tiền hoạt động so với dòng tiền tự do.
Khả năng sinh lờiDiễn biến biên gộp, biên hoạt động và biên ròng.
Dữ liệu tài chính tại thời điểm được dùng trong phân tích ngày 2026-10-05.
Dữ liệu lịch sử tài chính
Kỳ
Doanh thu
EBITDA
Lợi nhuận ròng
Dòng tiền hoạt động
Dòng tiền tự do
Capex
Khấu hao và phân bổ
Thù lao bằng cổ phiếu
Mua lại cổ phiếu
Cổ tức đã trả
Phát hành nợ ròng
Dòng tiền đầu tư
Dòng tiền tài chính
Tiền đầu kỳ
Tiền cuối kỳ
Tiền mặt và đầu tư
Tổng nợ
Biên hoạt động
ROIC
WACC
Chênh lệch ROIC−WACC
2016-12-31
13,5 T US$
2,8 T US$
1,6 T US$
1,6 T US$
1,3 T US$
300 Tr US$
379 Tr US$
217 Tr US$
512 Tr US$
0 US$
—
-963 Tr US$
-743 Tr US$
—
2 T US$
5,2 T US$
881 Tr US$
17,0%
—
6,5%
—
2017-12-31
14,8 T US$
3,1 T US$
1,5 T US$
2,4 T US$
2,1 T US$
284 Tr US$
443 Tr US$
221 Tr US$
1,9 T US$
265 Tr US$
—
-582 Tr US$
-2 T US$
2 T US$
1,9 T US$
5,1 T US$
800 Tr US$
16,8%
—
5,8%
—
2018-12-31
16,1 T US$
3,3 T US$
2,1 T US$
2,6 T US$
2,2 T US$
377 Tr US$
498 Tr US$
267 Tr US$
1,3 T US$
468 Tr US$
—
-1,6 T US$
-1,7 T US$
1,9 T US$
1,2 T US$
4,5 T US$
750 Tr US$
17,4%
—
6,0%
—
2019-12-31
16,8 T US$
3,1 T US$
1,8 T US$
2,5 T US$
2,1 T US$
392 Tr US$
526 Tr US$
217 Tr US$
2,2 T US$
453 Tr US$
—
1,6 T US$
-2,6 T US$
1,2 T US$
2,6 T US$
3,4 T US$
1,7 T US$
14,6%
—
4,8%
—
2020-12-31
16,7 T US$
2,7 T US$
1,4 T US$
3,3 T US$
2,9 T US$
398 Tr US$
559 Tr US$
232 Tr US$
1,6 T US$
480 Tr US$
—
-1,2 T US$
-2 T US$
2,6 T US$
2,7 T US$
2,7 T US$
1,8 T US$
12,7%
—
4,9%
—
2021-12-31
18,5 T US$
3,4 T US$
2,1 T US$
2,5 T US$
2,2 T US$
279 Tr US$
574 Tr US$
246 Tr US$
771 Tr US$
509 Tr US$
—
-2,2 T US$
-1,2 T US$
2,7 T US$
1,8 T US$
2,7 T US$
1,6 T US$
15,3%
—
5,6%
—
2022-12-31
19,4 T US$
3,6 T US$
2,3 T US$
2,6 T US$
2,2 T US$
332 Tr US$
569 Tr US$
261 Tr US$
1,4 T US$
564 Tr US$
-36 Tr US$
-106 Tr US$
-1,9 T US$
1,8 T US$
2,3 T US$
2,5 T US$
1,5 T US$
15,3%
—
7,9%
—
2023-12-31
19,4 T US$
3,4 T US$
2,1 T US$
2,3 T US$
2 T US$
317 Tr US$
555 Tr US$
176 Tr US$
1,1 T US$
591 Tr US$
-25 Tr US$
-331 Tr US$
-1,6 T US$
2,3 T US$
2,7 T US$
2,6 T US$
1,3 T US$
13,9%
—
8,2%
—
2024-12-31
19,7 T US$
3,5 T US$
2,2 T US$
2,1 T US$
1,8 T US$
297 Tr US$
542 Tr US$
175 Tr US$
605 Tr US$
600 Tr US$
227 Tr US$
-1,6 T US$
-915 Tr US$
2,7 T US$
2,2 T US$
2,2 T US$
1,5 T US$
14,7%
—
9,0%
—
2025-12-31
21,1 T US$
4,2 T US$
2,2 T US$
2,9 T US$
2,6 T US$
288 Tr US$
550 Tr US$
181 Tr US$
1,4 T US$
610 Tr US$
-342 Tr US$
-230 Tr US$
-2,3 T US$
2,2 T US$
2,6 T US$
1,9 T US$
1,6 T US$
16,1%
—
8,2%
—
§9 So sánh định giá với các doanh nghiệp cùng ngành
Giá trị hợp lýReport-date price
Cognizant Technology Solutions CorporationCTSH
Giá / giá trị hợp lý
Giá trị hợp lý94,37 US$Report-date price58,17 US$
Ngày đánh giá
Hào kinh tếNarrow
Bảng điểm đầu tư71 / 100
Jack Henry & Associates, Inc.JKHY
Giá / giá trị hợp lý
Giá trị hợp lý183,66 US$Report-date price154,85 US$
Ngày đánh giá
Hào kinh tếWide
Bảng điểm đầu tư72 / 100
Gartner, Inc.IT
Giá / giá trị hợp lý
Giá trị hợp lý213,73 US$Report-date price185,78 US$
Cognizant Technology Solutions Corporation (CTSH) trades at 9.4x forward earnings against a peer median of 18.6x. Its EV/EBITDA of 6.8x compares with a peer median of 15.3x. The comparison uses 4 peers: Jack Henry & Associates Inc., Gartner Inc., Teledyne Technologies Incorporated and ON Semiconductor Corporation, as of 2026-10-04 to 2026-10-05.
§10 Ngành và chu kỳEN
Pha chu kỳ
Contraction
Industry benchmark capex-to-revenue stands at 2.9% (industry.industry_capex_to_revenue of -0.029) and capex-to-depreciation is 0.35 (industry.industry_capex_to_depreciation), reflecting asset-light reinvestment. Cognizant's own capex of $288M on $21,108M revenue, (~1.36%) demonstrates modest physical capital intensity. Because capacity, supply, and lead-time metrics are not tracked directly in IT services, this cycle view is demand-led and evidence-limited.6
Chu kỳ tăng giá
Accelerating enterprise commitments to generative AI implementation, enterprise cloud migration, and ERP modernization expand corporate IT consulting budgets beyond defensive maintenance, increasing contract size and billing rates.
Chu kỳ giảm giá
Prolonged high interest rates (risk-free rate 5.24%) freeze discretionary enterprise transformation projects, prompting corporate clients to defer software updates, seek vendor rate concessions, and slow new deal sign-offs.
Xu hướng dài hạn
Xu hướng
Tác động
Ghi chú
Enterprise Generative AI and Cloud Modernization
positive
Enterprises are modernizing legacy infrastructure and embedding generative AI into automated workflows, creating durable demand for application modernization and cloud engineering consulting.
Offshore Delivery Wage Inflation and Automation of Application Maintenance
neutral
Rising technical compensation in India requires IT services vendors to deploy internal AI code generation tools and expand delivery into lower-cost regional hubs to protect operating margins.
Định vị
Cognizant is strongly positioned as a top-tier global IT services provider with $21,108M in FY2025 revenue, characterized by defensive specialization in Health Sciences ($6,347M) and Financial Services ($6,173M). While 74.8% of revenue is derived from North America ($15,780M), its European expansion ($4,012M) provides a multi-billion dollar growth buffer against domestic budget cycles.6,7
§11 Quản lý vị thếEN
Quy mô vị thế
5-7%
High conviction is supported by CTSH's low net debt balance sheet ($1,901M cash vs $2,094M total debt, or $193M net debt), $2,595M in free cash flow, 62.2% upside to Fair value midpoint ($94.37) from analysis price ($58.17), and defensible revenue streams in Health Sciences ($6,347M) and Financial Services ($6,173M).2,3,5,6,7
Rủi ro
Portfolio risk management is anchored by Cognizant's robust balance sheet liquidity ($1,901M cash and short-term investments against $2,094M total debt, representing modest net debt of $193M) and strong cash conversion ($2,595M FY2025 free cash flow). Position risk is managed through quarterly monitoring of operating margins and client renewal rates in Health Sciences and Financial Services, which together represent 59.3% of revenue,. Position sizing is capped at 7% of total portfolio equity to limit single-name enterprise IT spending exposure.
Đợt vào lệnh
Mức
Hành động
Lý do
$58.17 (analysis price)
Initiate primary position (50% of target allocation)
Cognizant presents an exceptional value compounder profile. Trading at 9.41x forward P/E against an intrinsic Fair value of $94.37, the company converts over $2,500M in annual free cash flow to retire shares and compound per-share earnings.3,5
Core Total Return & Growth
Buy
Total return investors benefit from multiple re-rating toward normalized IT peer levels (13.5x terminal multiple) and mid-single-digit top-line expansion to $23,250M by FY2027, supported by expanding digital transformation and generative AI engagements.1
Defensive & Quality-Focused
Buy
Low financial leverage with $1,901M in cash against $2,094M in total debt, combined with high recurring revenue from multi-year managed services contracts, provides substantial downside protection during macroeconomic retrenchment.2,6
§14 Khuyến nghị cuối cùngEN
Hành động
Mua mạnh
We recommend establishing a high-conviction position in Cognizant Technology Solutions Corporation. At the report-date price of $58.17, the stock is priced at a 38.36% discount to our intrinsic Fair value of $94.37, offering 62.23% upside. The company's massive enterprise scale ($21,108M FY2025 revenue), high-margin specialized verticals in Health Sciences and Financial Services,, and capital-light operations ($288M capex) produce robust free cash flow of $2,595M. Ongoing share retirements from 489M in FY2025 to 473M as of October 2026 compound per-share earnings power toward consensus FY2027 estimates of $6.33.1,3,5,6,7
Investors should capitalize on the current market mispricing driven by near-term macroeconomic caution regarding enterprise consulting budgets. With total debt of $2,094M offset by $1,901M in cash reserves, Cognizant possesses balance sheet flexibility to maintain buybacks and navigate industry demand cycles while expanding in Europe ($4,012M revenue). Position sizing should reflect high conviction with standard monitoring of quarterly North American constant-currency growth and offshore margin stability.
§15Your notes
Capture your own thesis, position size, and follow-up questions. Stays on this device, only you can see it.
Private notes
Visible only to you. Synced to this device.
0 chars
Sources
The records this analysis drew on, as they stood when it was run.
Market and peer researchData as of 2026-10-04 · Published 2026-10-04 · Provider-adjusted · cited for 3 figuresCited in Lợi thế cạnh tranh, Kịch bản tiêu cực
Not every cited input appears here: internal calculations and intermediate model outputs have no external record, and some citations could not be matched to one.
Severe North American IT Budget Retrenchment and Contract Deferrals
With North America generating $15,780M (74.8%) of total revenue, prolonged high interest rates (5.24% risk-free rate) could freeze discretionary spending, pushing organic revenue growth below 0.0% YoY and missing consensus FY2027 revenue of $23,250M.1,2,7
FV impact
-4.1%
Revenue and EPS growth 5 points lower for five years
If commoditization of application maintenance accelerates due to automation tools, CTSH's terminal multiple would fail to expand toward the modeled 13.5x, remaining capped below 10.8x, aligned with peer Gartner's 11.30x and close to CTSH's current forward P/E of 9.41x.3,4
Severe North American discretionary IT budget retrenchment freezes corporate consulting spending, directly hitting 74.8% of the revenue base ($15,780M) and disconfirming core modernization demand.
Hiện tại:5.15% projected FY2026; 4.74% projected FY2027 ($23,250M)
Cảnh báo nếu<=0.0% YoY (or constant-currency growth <2.0% for two consecutive quarters)
Signals European market saturation or competitive displacement by regional European systems integrators, undermining geographic diversification and leaving performance tethered to North America.
Hiện tại:$4,012M in FY2025 ($1,922M UK, $2,090M Continental Europe)
Cảnh báo nếu<=0.0% YoY in constant currency for a full fiscal year
Long-term recurring managed services contracts, mission-critical regulatory software support, and active positioning in cost-takeout and vendor consolidation pursuits.
Commoditization of routine application services by automation and AI tools
medium
24 to 36 months
Investing in proprietary vertical domain platforms, strategic AI partnerships, and pivoting delivery capabilities toward complex cloud and digital engineering modernization.
Discounted forecast-period cash flows (21,97 US$) plus discounted terminal value (76,45 US$) minus signed per current share (-0,72 US$) equals the 99,14 US$ lens value shown above. Negative net debt is , so subtracting it raises value.
Accelerated share repurchases reduce diluted shares outstanding each year
European geographic expansion outpaces domestic market growth
In the bull case, enterprise digital transformation spending re-accelerates as large corporate clients aggressively deploy generative AI workflows and modern cloud architecture. Health Sciences and Financial Services expand above historical mid-single-digit rates, and European market share gains accelerate across the United Kingdom and Continental Europe. Operational leverage and delivery automation expand operating margins, while disciplined free cash flow conversion accelerates share count retirement. This trajectory targets $116.80 with an assigned probability of 20.0%, offering an implied return of 100.8% from $58.17.
Chỉ số:
Organic revenue growth and discretionary IT consulting demand
Hiện tạiTop-line expansion remains steady, anchored by recurring multi-year enterprise managed services contracts.
Vì sao quan trọng
Top-line growth indicates enterprise client willingness to fund modernization programs rather than deferring discretionary software development under elevated interest rates.
03
Chỉ số:
Health Sciences vertical expansion and regulatory software deal bookings
Hiện tạiSegment execution demonstrates robust client retention and consistent contract renewals.
Vì sao quan trọng
Health Sciences represents the largest industry segment, where regulatory software and payer platform entrenchment drive premium segment operating profit.
04
Chỉ số:
European regional revenue growth across the UK and Continental Europe
Hiện tạiEuropean operations continue to generate multi-billion dollar scale and expand commercial pipeline.
Vì sao quan trọng
European contract expansion validates geographic diversification, reducing reliance on mature North American enterprise IT budgets.
Capital allocation is heavily centered on returning surplus cash flow to shareholders via disciplined share repurchases and regular dividends, supplemented by tuck-in domain acquisitions. With cash of $1,901M against total debt of $2,094M, Cognizant maintains modest net debt of $193M. Free cash flow of $2,595M in FY2025 funded regular dividend distributions of $1.32 per share and aggressive share repurchases that reduced diluted average shares from 489M in FY2025 to 473M shares outstanding as of October 5, 2026.
Low physical capital requirements enable virtually all net earnings to be translated into free cash flow for capital distribution and strategic investment.
Vertical profitability is anchored by healthcare and banking specialization
Financial Services generated a 19.97% operating margin ($1,233M operating income on $6,173M revenue) and Health Sciences delivered 16.21% ($1,029M on $6,347M), while Communications, Media & Technology lagged at 13.20% ($436M on $3,303M).
Consolidated operating margins remain highly reliant on healthcare and financial services to offset margin drag in telecommunications and discretionary consulting.
Share repurchases accelerate per-share earnings power compounding
Diluted average shares dropped from 489M in FY2025 to 473M shares outstanding as of October 5, 2026, following $1,378M in share repurchases in FY2025.
Consistent share count retirement compounds diluted EPS growth at a rate 1.5-2.0 percentage points faster than top-line revenue expansion.
Teledyne Technologies IncorporatedTDY
Giá / giá trị hợp lý
Giá trị hợp lý460,57 US$Report-date price621,02 US$
Ngày đánh giá
Hào kinh tếNarrow
Bảng điểm đầu tư64 / 100
ON Semiconductor CorporationON
Giá / giá trị hợp lý
Giá trị hợp lý46,4 US$Report-date price76,94 US$
Ngày đánh giá
Hào kinh tếNarrow
Bảng điểm đầu tư60 / 100
Biên
CTSH
Cognizant Technology Solutions Corporation
$27.5B
9.4x
1.3x
6.8x
14.9%
—
JKHY
Jack Henry & Associates Inc.
$10.2B
18.4x
4.0x
14.3x
24.0%
22.5%
IT
Gartner Inc.
$11.7B
11.3x
1.8x
9.8x
113.6%
22.6%
TDY
Teledyne Technologies Incorporated
$28.8B
23.2x
4.5x
19.0x
9.2%
20.2%
ON
ON Semiconductor Corporation
$33.0B
18.7x
5.3x
16.2x
8.3%
19.5%
Regulatory Compliance Entrenchment in Healthcare and Financial Services
positive
Evolving regulatory reporting and compliance standards in healthcare, life sciences, and global banking reinforce multi-year demand for specialized domain IT systems.
Add second tranche (30% of target allocation)
Capitalize on potential short-term macroeconomic volatility or broad IT sector pullbacks to lower average cost basis.
$47.00 - $50.00
Complete position to maximum allocation (remaining 20%)
Approaching sell-side consensus low target ($47.00), providing deep value protection backed by net cash balance sheet.
Re-examine competitive positioning against systems integrators and lower explicit revenue growth path across valuation models.
